| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.066 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.031 | 0.6 |